641 related articles for article (PubMed ID: 23537464)
1. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
2. Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.
Silva JP; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
Colloids Surf B Biointerfaces; 2014 Sep; 121():371-9. PubMed ID: 25023903
[TBL] [Abstract][Full Text] [Related]
3. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.
Tezgel Ö; Szarpak-Jankowska A; Arnould A; Auzély-Velty R; Texier I
J Colloid Interface Sci; 2018 Jan; 510():45-56. PubMed ID: 28934610
[TBL] [Abstract][Full Text] [Related]
5. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
Hosseini ES; Nikkhah M; Hosseinkhani S
Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
[No Abstract] [Full Text] [Related]
8. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
10. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
11. SPANosomes as delivery vehicles for small interfering RNA (siRNA).
Zhou C; Mao Y; Sugimoto Y; Zhang Y; Kanthamneni N; Yu B; Brueggemeier RW; Lee LJ; Lee RJ
Mol Pharm; 2012 Feb; 9(2):201-10. PubMed ID: 22149175
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
Jeon SY; Park JS; Yang HN; Woo DG; Park KH
Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
[TBL] [Abstract][Full Text] [Related]
13. Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes.
Remaut K; Sanders NN; Fayazpour F; Demeester J; De Smedt SC
J Control Release; 2006 Oct; 115(3):335-43. PubMed ID: 17010468
[TBL] [Abstract][Full Text] [Related]
14. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
15. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
Falsini S; Ristori S
Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
[TBL] [Abstract][Full Text] [Related]
16. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
Wang J; Feng SS; Wang S; Chen ZY
Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
[TBL] [Abstract][Full Text] [Related]
18. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells.
Malakooty Poor E; Baghaban Eslaminejad M; Gheibi N; Bagheri F; Atyabi F
Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):376-84. PubMed ID: 24001051
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]